Predictive oncology inc.'s subsidiaries soluble biotech inc. and tumorgenesis inc. are both constructing new gmp labs

Minneapolis, june 22, 2021 (globe newswire) -- predictive oncology (nasdaq: poai), an ai-driven oncology and drug discovery company, announced today that two of their wholly owned subsidiaries, soluble biotech inc. and tumorgenesis inc. are both expanding their unique services by completing the fabrication and qualification of gmp facilities.
POAI Ratings Summary
POAI Quant Ranking